Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Post by Fishercat1on Dec 16, 2020 6:51pm
141 Views
Post# 32124734

Another Good Thing About Our First Big Run .

Another Good Thing About Our First Big Run . All lot of cheap paper if not all good cleaned up and strengthed the balence sheet big time so adding more money for the buil up of stores coming in early Jan and beyone . There was a money concern but no longer . Add the assets from shares and lots of money if need to move forward and add share holder value . Terry Booth had options at 11 cents . So a great first run and lots more coming . Did any of your sellers not read the Corporate update like really ?? . Yah I get it . In and out for a fast buck profit . This is a part of the Corporate update . IMO it gave clear guidence where this stock is going and thats much higher with time and some patience and sooner then you think if you can read  . Cheers .  Thirdly, the Company is now receiving conversion notices of its outstanding debentures which have a conversion feature at $0.05 per share. As a result, the Company has already seen a material decrease in its outstanding debt since Q3 financials. We will update the market on the debenture principal outstanding prior to year-end. Lastly, the company has a sizeable amount of $0.05 warrants in the market and management has already received a number of exercise notices. In summary, management expects to see a large increase in its cash balance by year-end with a greatly reduced outstanding debt balance.
<< Previous
Bullboard Posts
Next >>